Corsair Gaming Inc vs Smith & Nephew plc — how do they compare? Corsair Gaming Inc trades at $13.63 (market cap $1.42B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Smith & Nephew plc is far larger — about 7.8× Corsair Gaming Inc's market cap, and Smith & Nephew plc pays a 2.95% dividend while Corsair Gaming Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corsair Gaming Inc for 25 Days and Smith & Nephew plc for 121 Days on average.
| CRSR | SNN | |
|---|---|---|
Market Cap | $1.42B | $11.10B |
Volume | 1,160,938 | 1,051,703 |
Sector | Technology | Health |
52-Week High | $14.35 | $37.17 |
52-Week Low | $4.58 | $26.42 |
Typical Hold Time | 25 Days | 121 Days |
Enterprise Value | $1.41B | $14.13B |
Dividend Yield | — | 2.95% |
Signals from Pluang's Aura AI — not financial advice
CRSR trades at $13.09, down 3.68% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.23, beating estimates of $0.07, and raised full-year guidance. Revenue for 2025 was $1.47B, with a net income margin of 2.53% in 2026 projections. Analyst consensus is a $12.40 price target with a mix of Buy (36%) and Hold (64%) ratings. Recent news includes product launches like the VOXARA microphone and strategic acquisitions.
Outlook is cautiously optimistic due to strong earnings performance and new product initiatives, but risks include competitive pressures in gaming hardware and volatile cash flow trends. The stock's valuation at a P/E of 42.23 may limit near-term upside unless profit growth accelerates. Institutional interest is positive, with Canada Pension Plan adding a position in Q3 2026.
SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.
The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →